Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer

Stiekema, A; Lok, CAR; Korse, CM; van Driel, WJ; van der Noort, V; Kenter, GG; Van de Vijver, KK

Stiekema, A (reprint author), NKI AVL, Ctr Gynaecol Oncol Amsterdam, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.

VIRCHOWS ARCHIV, 2017; 470 (6): 655

Abstract

The extent of surgery and the decision for adjuvant treatment in patients with endometrial cancer (EC) depend on the presence of risk factors for lymp......

Full Text Link